Doctor profile · Federal record
Dr. Mark Reding, MD
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Internal Medicine Physician · Minneapolis, MN
- NPI 1336223866
- Accepts Medicare
- MIPS 78.9 / 100 · 2023
- 34 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
420 Delaware St Se, Mmc 480
Minneapolis, MN 554550341
(612) 625-1104
Credentials & registration
- NPI registered
- October 2006 — 20 yrs on file
- Profile last updated
- January 4, 2013
- Year of graduation
- 1992 — 34 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Minnesota #37501
- Medicaid
- MN #182278100
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1336223866. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
105
Distinct HCPCS
3
Medicare allowed
$13,392
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 50 | 38 | $135 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 35 | 31 | $94 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 20 | 17 | $168 |
In context: peer comparison
Among 25 peers in Minneapolis Hematology & Oncology Physician, average services per provider: 454. This provider delivers 0.2× the peer median.Open Payments
Industry payments received
All-time total
$73,220
Transactions
66
Manufacturers
8
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Genzyme Corporation | 8 | $18,507.73 | |
| Bayer Healthcare Pharmaceuticals INC. | 18 | $13,368.90 | |
| Hema Biologics, LLC | 22 | $12,853.44 | |
| Novo Nordisk INC | 5 | $9,868.40 | |
| BioMarin Pharmaceutical INC. | 8 | $9,382.87 | |
| Csl Behring | 2 | $3,650.00 | |
| Sanofi-Aventis U.S. LLC | 1 | $3,559.50 | |
| Genentech USA, INC. | 2 | $2,028.91 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
386
Patients
45
Total drug cost
$479,822
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Xarelto (Rivaroxaban) | Brand | 71 | 19 | $74,240 |
| Oxycodone Hcl | Generic | 68 | 11 | $1,575 |
| Warfarin Sodium | Generic | 50 | 15 | $1,295 |
| Eliquis (Apixaban) | Brand | 42 | 0 | $32,415 |
| Jantoven (Warfarin Sodium) | Brand | 37 | 0 | $701 |
| Oxycontin (Oxycodone Hcl) | Brand | 26 | 0 | $101,169 |
| Fondaparinux Sodium | Generic | 20 | 0 | $31,381 |
| Hydroxyurea | Generic | 19 | 0 | $932 |
| Hydromorphone Hcl | Generic | 15 | 0 | $529 |
| Celecoxib | Generic | 14 | 0 | $617 |
Frequently asked questions
What is Dr. Mark Reding's medical specialty?
Dr. Mark Reding practices Hematology & Oncology Physician in Minneapolis, MN.
Where does Dr. Mark Reding practice?
Dr. Mark Reding practices at 420 Delaware St Se, Minneapolis, MN 554550341. Office phone: 6126251104.
What is Dr. Mark Reding's NPI?
Dr. Mark Reding's National Provider Identifier (NPI) is 1336223866, issued by NPPES.
Does Dr. Mark Reding accept Medicare assignment?
Yes. Dr. Mark Reding accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mark Reding commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99215); Established patient office or other outpatient visit (HCPCS 99214); Initial hospital care with moderate level of medical decision making (HCPCS 99223). Source: CMS Medicare Physician & Other Practitioners file.